Bionano Genomics, Inc. — Director's Dealing 2021

May 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2021-05-12

Reporting Person: Holmlin R. Erik (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-12	Common Stock	A	290000	$0.00	Acquired	295191	Direct
2021-05-12	Common Stock	A	290000	$0.00	Acquired	585191	Direct

Footnotes

F1: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.

F2: Includes: 218 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on December 10, 2018, 450 shares acquired under the ESPP on June 10, 2019, 728 shares acquired under the ESPP on December 10, 2019, 1,014 shares acquired under the ESPP on June 10, 2020 and 1,151 shares acquired under the ESPP on December 10, 2020.